BioTech 365

DECEMBER 20, 2021

Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics) – ResearchAndMarkets.com Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & (..)

Genetic Engineering 40

Genetic Engineering Engineer Genome Genomics 40

Advarra

JUNE 12, 2023

IBCs, however, seek to protect study personnel, the community, and the environment from exposure to engineered genetic material and other biohazardous agents. The IBC’s review is intended to ensure a thorough risk assessment is performed regarding the risks associated with the genetically modified materials.

Genetic Engineering 98

Genetic Engineering Gene Therapy Genetics Engineer 98

XTalks

MARCH 21, 2024

The products contain ingredients like bamboo fiber, pea protein and mushrooms. Additionally, the offerings have the distinctive “snap” of the outer casing and the savory smokiness of Oscar Mayer products. The study also highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens.

Genetic Engineering 98

Genetic Engineering Production Engineer Containment 98

Scienmag

JULY 1, 2021

Genetic technique edits every chloroplast in a plant, but does not change nuclear DNA of offspring Credit: Image by Hiroko Uchida CC BY-SA 4.0, [link] Breeding better crops through genetic engineering has been possible for decades, but the use of genetically modified plants has been limited by technical challenges and popular controversies.

Genetic Engineering 55

Genetic Engineering Genetics DNA Engineer 55

XTalks

JULY 29, 2021

This cheese is different from other plant-based cheeses because the start-up uses genetically engineered soybeans to produce plant-based casein. The taste and stretch of dairy cheese are due to the casein found in milk products. s FootPrint Coalition Ventures. Nobell Cheese began in 2017 in California.

Protein 98

Protein Genetic Engineering Genetics Production 98

pharmaphorum

SEPTEMBER 4, 2020

The treatments are developed using cutting- edge technologies such as genomic sequencing and genetic engineering, helping to account for the individual variability in both patient and disease characteristics. This means not only adopting collaborative thinking during the design phase but also during production and development.

Medicine 59

Medicine Production Genetic Engineering Genetics 59

BioTech 365

OCTOBER 28, 2020

Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an … Continue reading → RTX-321 Induces Antigen-Specific Stimulation Combined with Broad Stimulation of Innate and Adaptive Immune Responses CAMBRIDGE, Mass.,

Genetic Engineering 40

Genetic Engineering Immune Response Engineer Genetics 40

Scienmag

OCTOBER 14, 2020

Scientists prove cell-cultured meat products can offer enhanced nutrition compared to conventionally produced meat A group of researchers at Tufts University have genetically engineered cow muscle cells to produce plant nutrients not natively found in beef cells.

Engineer 40

Engineer Genetic Engineering Genetics Scientist 40

Advarra

OCTOBER 26, 2023

Ensuring the safe and secure transport of investigational products (IP) is a core part of biosafety. Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines.

Production 52

Production Containment Biohazard Biohazard 52

Pharmaceutical Technology

APRIL 5, 2023

With blood cancers, you inject the product, and the cells are there, and the target is there. But I think we’ve never had more tools than we have now in synthetic biology, genetic engineering, enhanced potency design switches and CRISPR. Exa-cel is almost certainly going to the first CRISPR engineered product [to be approved].

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

FDA Law Blog

DECEMBER 8, 2022

1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. Other technical labeling matters. 1, 2023, sesame.

Genetic Engineering 59

Genetic Engineering Containment Cosmetics Protein 59

pharmaphorum

AUGUST 23, 2021

DNA vaccines work by delivering a genetically-engineered plasmid containing the DNA sequence encoding the desired antigen – in this case the SARS-CoV-2 spike protein – which is then taken up by cells.

DNA 98

DNA Vaccination Vaccine Genetic Engineering 98

XTalks

MARCH 18, 2024

By genetically editing microorganisms, scientists can now manipulate the metabolic pathways to produce foods with desirable properties. The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

WCG Clinical

NOVEMBER 17, 2023

Although the NIH Guidelines were originally written with non-clinical laboratory research in mind, they also apply to human gene transfer (HGT) research, wherein rsNA or rsNA-containing products are administered to research participants. Since then, however, certain genetic engineering technologies (e.g.,

Genome 52

Genome Genomics Gene Editing Genetic Engineering 52

Advarra

AUGUST 8, 2023

Gene therapy involves the transfer of engineered genetic materials to human research subjects. As of June 2023, 416 Phase III studies are listed, representing a growing pipeline of gene therapy products preparing to undergo consideration for FDA approval.

Gene Therapy 52

Gene Therapy Gene Research Genetics 52

XTalks

NOVEMBER 23, 2020

Developed by researchers at the University of Oxford, the COVID vaccine is an adenovirus vector-based vaccine derived from chimpanzees that contains a genetically engineered virus that causes the common cold in chimpanzees, along with the spike protein of the SARS-CoV-2 coronavirus.

Vaccination 97

Vaccination Vaccine Clinical Trials Clinical Trials 97

pharmaphorum

MAY 7, 2021

Founded by Nobel prize winner Emmanuelle Charpentier, CRISPR Therapeutics has been at the forefront of the gene editing technology and has refined it to the point where it can be used to accurately edit DNA to correct genetic conditions or modify cells to fight disease.

Gene Editing 52

Gene Editing Gene Genetic Engineering DNA 52

FDA Law Blog

SEPTEMBER 29, 2022

Plaintiffs challenged the use of the term bioengineered (rather than GMO or genetically engineered), the limitation of the mandatory disclosure being required only if the food contains detectable modified genetic material and the options of using a QR code disclosure or a text message for the disclosure statement.

Genetic Engineering 59

Genetic Engineering Containment Genetics Regulation 59

The Pharma Data

JANUARY 19, 2021

A range of companies are exploring potential gene editing therapies based on a CRISPR-Cas9 system, and the ability to tune the CRISPR cut could prevent off-target editing or control the degree of a target protein’s production. The authors found that tracr-L redirects Cas9 in S. The authors suggest natural tracr-L regulates autoimmunity.

Bacteria 52

Bacteria Gene Editing Research RNA 52

Bioengineer

JULY 19, 2021

These findings suggest that for therapies to be effective, they must be targeted at both gene products. KRAS encodes two gene products, KRAS4A and KRAS4B, whose levels can vary across organs and embryonic stages. Credit: CNIO. KRAS was one of the first oncogenes to be identified, a few decades ago.

Research 52

Research Gene Genetic Engineering Genetics 52

Cloudbyz

MARCH 5, 2024

The difference between biologics vs small molecules in pharma drug development In pharmaceutical drug development, biologics and small molecules represent two distinct categories of medicinal products, each with their own unique characteristics, development processes, and mechanisms of action.

Development 97

Development Drugs Immune Response Manufacturing 97

Roots Analysis

MARCH 16, 2023

It is important in the process of protein synthesis because mRNA is responsible for transferring genetic information from DNA to ribosomes, which then decodes the genetic information into a protein. Messenger ribonucleic acid (mRNA) is a single-stranded molecule that is complementary to a gene’s DNA.

Vaccination 52

Vaccination Vaccine DNA Protein 52

The Pharma Data

DECEMBER 16, 2020

The company will work with Medsafe, New Zealand’s regulatory agency, to obtain product approvals as needed. Food and Drug Administration, European Medicines Agency and/or Medicines and Healthcare products Regulatory Authority in the United Kingdom. Additional terms of the agreement were not disclosed. About NVX-CoV2373.

Protein 52

Protein Vaccination Vaccine Immune Response 52

The Pharma Data

JANUARY 27, 2021

Inspired by the function and versatility of platelets, PlateletBio is pioneering the next generation of safer, more effective allogeneic cell therapy products. The company, based in Watertown, Mass.,

Genetic Engineering 40

Genetic Engineering Gene Therapy Gene Engineer 40

The Pharma Data

JULY 27, 2021

This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. About Teneobio Teneobio, Inc.

Production 52

Production Antibody Sales Development 52

pharmaphorum

NOVEMBER 2, 2021

Though their bispecific nature complicates large-scale production and purification workflows, with challenges such as antibody chain mispairing, bsAbs have come a long way since first developed. This lack of complexity also promotes simpler production workflows, offering the advantage of reduced costs and high yields.

Antibody 52

Antibody Immune Response Production Engineer 52

The Pharma Data

NOVEMBER 30, 2020

CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix?M. About NVX-CoV2373 NVX-CoV2373 is a protein-based vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease.

Clinical Development 52

Clinical Development Vaccination Vaccine Development 52

The Pharma Data

NOVEMBER 9, 2020

NVX-CoV2373 is a vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. Statements herein relating to the future of Novavax and the ongoing development of its vaccine and adjuvant products are forward-looking statements. About NVX-CoV2373. Novavax Forward-Looking Statements.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 26, 2020

These mAbs are already of human origin and functionally optimized for high potency by the donor’s immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.

Antibody 52

Antibody Genetic Engineering Development Clinical Trials 52

The Pharma Data

NOVEMBER 4, 2020

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). million and US$1.8 About Juyou Bio – Technology Co. Juyou Bio-Technology Co.,

Licensing 40

Licensing Licensing Dermatology Production 40

The Pharma Data

APRIL 27, 2023

It is also an off-the-shelf therapy, meaning that people do not have to wait for cell collection and genetic engineering before starting treatment, which could be particularly important for patients who are at a high-risk of their disease progressing. Roche’s Chief Medical Officer and Head of Global Product Development.

Genetic Engineering 40

Genetic Engineering Clinical Development Antibody Medicine 40

ACRP blog

OCTOBER 8, 2024

She is a certified IRB professional (CIP) and holds a BS in Chemical Engineering from the University of New Hampshire and a PhD in Chemical Engineering from the University of Washington. Her graduate training was in genetic engineering, which led to an interest in medical diagnostic device technology.

Regulation 59

Regulation Research Engineer Compliance 59

The Pharma Data

OCTOBER 27, 2020

“As our core business continues to perform well, we have a solid footing to enter 2021 with several key product launches including the potential INCREASE product label expansion for Tyvaso, the Remunity Pump for Remodulin, and the Implantable System for Remodulin,” said Martine Rothblatt , Ph.D., SILVER SPRING, Md.

Production 40

Production Sales Licensing Licensing 40

Pharmaceutical Technology

JUNE 4, 2023

Transfection of plasmids for rAAV production can initiate transcription directly from the dsDNA of these plasmids. Encoded Therapeutics develops gene therapies for the treatment of severe genetic disorders. The company is headquartered in South San Francisco, California, US.

Gene 262

Gene Gene Therapy Genetics DNA 262

Advarra

JUNE 13, 2024

Recombinant DNA technologies and genetically modified biological agents are being adapted for a wide scope of therapeutic applications, and their use is becoming increasingly common in clinical trials. How can I protect myself from exposure? What should I do if I’m exposed?

Genetic Engineering 52

Genetic Engineering Clinical Trials Clinical Trials Engineer 52

Pharmaceutical Technology

AUGUST 17, 2022

The alliance will merge the cell and media products and process development services of RoosterBio with the worldwide cell and gene therapy manufacturing expertise of AGC. . To create strong and scalable processes for hMSC and exosome therapies, RoosterBio will leverage its broad-ranging cell and media product portfolio.

Manufacturing 130

Manufacturing Gene Therapy Genetic Engineering Gene 130

Roots Analysis

SEPTEMBER 9, 2024

The rising demand for protein therapeutics, such as monoclonal antibodies and vaccines , is driving advancements in protein expression technology to ensure efficient and scalable production. In the healthcare industry, protein expression technology is primarily used for the production of therapeutic biologics and high-value small molecules.

Protein 40

Protein Gene Production DNA 40